HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie Horan Selected Research

((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acid

12/2008Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julie Horan Research Topics

Disease

3Neoplasms (Cancer)
04/2016 - 12/2008
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2016
1Ependymoma
01/2016

Drug/Important Bio-Agent (IBA)

2Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2016 - 01/2016
1130-nm albumin-bound paclitaxelIBA
04/2016
1GemcitabineFDA Link
04/2016
1ErbB Receptors (EGF Receptor)IBA
01/2016
1Etoposide (VP 16)FDA LinkGeneric
01/2016
1Cisplatin (Platino)FDA LinkGeneric
12/2008
1Biological ProductsIBA
12/2008
1Thymidylate SynthaseIBA
12/2008
1((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acidIBA
12/2008